Search

Search Constraints

You searched for: Author/Creator Li, Zengjun

Search Results

1. 1q21 gain but not t(4;14) indicates inferior outcomes in multiple myeloma treated with bortezomib. Issue 5 (15th April 2020)

2. BCL-2 and MYC gain/amplification is correlated with central nervous system involvement in diffuse large B cell lymphoma at leukemic phase. Issue 1 (December 2017)

3. Downregulated miR-33b is a novel predictor associated with disease progression and poor prognosis in multiple myeloma. Issue 7 (July 2015)

4. Hedgehog pathway is involved in nitidine chloride induced inhibition of epithelial-mesenchymal transition and cancer stem cells-like properties in breast cancer cells. Issue 1 (December 2016)

5. Long-term remissions of young patients with high-risk follicular lymphoma after first-line autologous stem cell transplantation: Three case reports. Issue 22 (29th May 2020)

7. Plerixafor and granulocyte‐colony‐stimulating factor for mobilization of hematopoietic stem cells for autologous transplantation in Chinese patients with non−Hodgkin's lymphoma: a randomized Phase 3 study. Issue 1 (13th December 2017)

8. Prominent immune signatures of T cells are specifically associated with indolent B‐cell lymphoproliferative disorders and predict prognosis. Issue 1 (22nd January 2020)